- Active Substance: Follistatin
- Concentration: 1 mg
- Pack Size: vial
- Manufacturer: Ultima Pharmaceuticals
- Brand Name: Follistatin
SKU: P262
Shipping From
Understanding Ultima-Follistion 344 (Follistatin) 1mg for Muscle Growth Research
Ultima-Follistion 344, offered by Ultima Pharmaceuticals, contains 1mg per vial of Follistatin, specifically the Follistatin-344 isoform. This protein is being actively investigated in muscle physiology research for its significant role as a potent inhibitor of myostatin, a naturally occurring protein that limits muscle growth.
Mechanism of Action
Follistatin-344 functions by binding to and neutralizing myostatin, effectively blocking myostatin's ability to inhibit muscle cell proliferation and differentiation. This inhibition of myostatin signaling pathways is a key area of research aimed at understanding and potentially overcoming the natural limitations on muscle hypertrophy (growth). Researchers are exploring the precise mechanisms by which Follistatin-344 interacts with myostatin and the downstream effects on muscle tissue.
Potential Research Benefits
- Investigated for its potential to promote significant increases in muscle mass by inhibiting myostatin.
- Studied for its effects on enhancing muscle strength and power.
- Research into its potential to improve muscle regeneration and recovery from injury.
- Exploration of its role in altering body composition by increasing lean muscle mass and potentially reducing fat tissue.
- Studies on its potential therapeutic applications in conditions characterized by muscle wasting.
Please note: The potential benefits listed above are based on preclinical and some limited clinical research and have not been fully established in humans for widespread therapeutic use. Follistatin-344 is a research compound and is not approved for human therapeutic use by regulatory authorities in many regions.
Usage Guidelines
As a research compound, any guidelines regarding its use are strictly within the context of laboratory and research settings. Administration protocols and dosages vary significantly depending on the specific research objectives and models. Common routes of administration in research include intramuscular or subcutaneous injection. Research protocols often involve specific dosing schedules and monitoring of muscle growth and related biomarkers. Any information regarding human dosage or administration is speculative and not recommended.
Potential Side Effects
Research on Follistatin-344 has indicated potential side effects, although the full long-term safety profile in humans is still under investigation. Some studies have reported localized injection site reactions. The systemic effects and potential for other side effects are areas of ongoing research.
FAQ
What is Ultima-Follistion 344 (Follistatin)?
Ultima-Follistion 344 contains Follistatin-344, a protein being researched for its ability to inhibit myostatin and promote muscle growth.
How does Follistatin-344 work in research for muscle growth?
Research shows it binds to and neutralizes myostatin, a protein that limits muscle growth, thereby potentially allowing for increased muscle development.
What are the potential research benefits of Follistatin-344?
Potential research benefits include significant muscle mass increases, enhanced strength, improved muscle regeneration, and altered body composition.
What are the potential side effects observed in research?
Research has reported potential localized injection site reactions. The full long-term safety profile is still under investigation.
Important Note: Ultima-Follistion 344 (Follistatin) is a research compound and is not approved for human therapeutic use by regulatory authorities in many regions. Information provided here is strictly for research and informational purposes only. It is not intended as a guide for personal use. The use of such compounds carries potential risks, and their long-term effects are not fully understood. Consult with qualified healthcare professionals for any health concerns.